119 related articles for article (PubMed ID: 36939422)
1. Candidate Angiogenesis-Related Biomarkers in Patients with Laryngeal Carcinoma (AngLaC): A Prospective Cohort Study.
Pamuk AE; Gedik ME; Sutay Suslu N; Gunaydin G
Otolaryngol Head Neck Surg; 2023 Jun; 168(6):1433-1442. PubMed ID: 36939422
[TBL] [Abstract][Full Text] [Related]
2. Serum angiopoietin-2 and soluble VEGFR-2 levels predict malignancy of ovarian neoplasm and poor prognosis in epithelial ovarian cancer.
Sallinen H; Heikura T; Koponen J; Kosma VM; Heinonen S; Ylä-Herttuala S; Anttila M
BMC Cancer; 2014 Sep; 14():696. PubMed ID: 25245329
[TBL] [Abstract][Full Text] [Related]
3. Up-regulation of soluble vascular endothelial growth factor receptor-1 prevents angiogenesis in hypertrophied myocardium.
Kaza E; Ablasser K; Poutias D; Griffiths ER; Saad FA; Hofstaetter JG; del Nido PJ; Friehs I
Cardiovasc Res; 2011 Feb; 89(2):410-8. PubMed ID: 20935166
[TBL] [Abstract][Full Text] [Related]
4. Combined VEGF-A and VEGFR-2 concentrations in plasma: diagnostic and prognostic implications in patients with advanced NSCLC.
Jantus-Lewintre E; Sanmartín E; Sirera R; Blasco A; Sanchez JJ; Tarón M; Rosell R; Camps C
Lung Cancer; 2011 Nov; 74(2):326-31. PubMed ID: 21481963
[TBL] [Abstract][Full Text] [Related]
5. The usefulness of determining the serum concentrations of vascular endothelial growth factor (VEGF) and its soluble receptor type 2 (sVEGF-2) in the differential diagnosis of adrenal incidentalomas.
Foltyn W; Strzelczyk J; Marek B; Kajdaniuk D; Siemińska L; Rosiek V; Kos-Kudła B
Endokrynol Pol; 2012; 63(1):22-8. PubMed ID: 22378094
[TBL] [Abstract][Full Text] [Related]
6. Soluble VEGF receptor-2 is increased in sera of subjects with metabolic syndrome in association with insulin resistance.
Wada H; Satoh N; Kitaoka S; Ono K; Morimoto T; Kawamura T; Nakano T; Fujita M; Kita T; Shimatsu A; Hasegawa K
Atherosclerosis; 2010 Feb; 208(2):512-7. PubMed ID: 19695569
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor-mediated decrease in plasma soluble vascular endothelial growth factor receptor-2 levels as a surrogate biomarker for tumor growth.
Ebos JM; Lee CR; Bogdanovic E; Alami J; Van Slyke P; Francia G; Xu P; Mutsaers AJ; Dumont DJ; Kerbel RS
Cancer Res; 2008 Jan; 68(2):521-9. PubMed ID: 18199548
[TBL] [Abstract][Full Text] [Related]
8. Association between intratumoral free and total VEGF, soluble VEGFR-1, VEGFR-2 and prognosis in breast cancer.
Bando H; Weich HA; Brokelmann M; Horiguchi S; Funata N; Ogawa T; Toi M
Br J Cancer; 2005 Feb; 92(3):553-61. PubMed ID: 15668703
[TBL] [Abstract][Full Text] [Related]
9. Circulating VEGF and its soluble receptors sVEGFR-1 and sVEGFR-2 in patients with acute leukemia.
Wierzbowska A; Robak T; Wrzesień-Kuś A; Krawczyńska A; Lech-Marańda E; Urbańska-Ryś H
Eur Cytokine Netw; 2003; 14(3):149-53. PubMed ID: 14656688
[TBL] [Abstract][Full Text] [Related]
10. Suppression of lymphangiogenesis by soluble vascular endothelial growth factor receptor-2 in a mouse lung cancer model.
Maehana S; Nakamura M; Ogawa F; Imai R; Murakami R; Kojima F; Majima M; Kitasato H
Biomed Pharmacother; 2016 Dec; 84():660-665. PubMed ID: 27697638
[TBL] [Abstract][Full Text] [Related]
11. [Assessment of pro- and antiangiogenic factors blood serum concentrations in patients with hormonal inactive adrenal tumors].
Korzeniewska M; Kołomecki K; Stepień H; Naze M; Stepień T; Kuzdak K
Endokrynol Pol; 2005; 56(1):39-44. PubMed ID: 16335673
[TBL] [Abstract][Full Text] [Related]
12. Soluble vascular endothelial growth factor receptor 2 and prognosis in patients with chronic heart failure.
Iguchi M; Wada H; Shinozaki T; Suzuki M; Ajiro Y; Matsuda M; Koike A; Koizumi T; Shimizu M; Ono Y; Takenaka T; Sakagami S; Morita Y; Fujimoto K; Yonezawa K; Yoshida K; Ninomiya A; Nakamura T; Funada J; Kajikawa Y; Oishi Y; Kato T; Kotani K; Abe M; Akao M; Hasegawa K;
ESC Heart Fail; 2021 Oct; 8(5):4187-4198. PubMed ID: 34387398
[TBL] [Abstract][Full Text] [Related]
13. CD31 and VEGF are prognostic biomarkers in early-stage, but not in late-stage, laryngeal squamous cell carcinoma.
Schlüter A; Weller P; Kanaan O; Nel I; Heusgen L; Höing B; Haßkamp P; Zander S; Mandapathil M; Dominas N; Arnolds J; Stuck BA; Lang S; Bankfalvi A; Brandau S
BMC Cancer; 2018 Mar; 18(1):272. PubMed ID: 29523110
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic and Prognostic Performance of Serum Vascular Endothelial Growth Factor, Vascular Endothelial Growth Factor Receptor 2, and Osteopontin for Gastrointestinal Cancers.
Jiang L; Hochwald S; Deng S; Chen Y; Tan C; Zhong Q; Huang H
Clin Lab; 2019 Jan; 65(1):. PubMed ID: 30775874
[TBL] [Abstract][Full Text] [Related]
15. Neuroblastoma progression correlates with downregulation of the lymphangiogenesis inhibitor sVEGFR-2.
Becker J; Pavlakovic H; Ludewig F; Wilting F; Weich HA; Albuquerque R; Ambati J; Wilting J
Clin Cancer Res; 2010 Mar; 16(5):1431-41. PubMed ID: 20179233
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor and its soluble receptors VEGFR-1 and VEGFR-2 in the serum of patients with systemic lupus erythematosus.
Robak E; Sysa-Jedrzejewska A; Robak T
Mediators Inflamm; 2003 Oct; 12(5):293-8. PubMed ID: 14760936
[TBL] [Abstract][Full Text] [Related]
17. Circulating biomarkers of bevacizumab activity in patients with breast cancer.
Denduluri N; Yang SX; Berman AW; Nguyen D; Liewehr DJ; Steinberg SM; Swain SM
Cancer Biol Ther; 2008 Jan; 7(1):15-20. PubMed ID: 18059178
[TBL] [Abstract][Full Text] [Related]
18. Determination of serum vascular endothelial growth factor (VEGF) and VEGF receptor levels with VEGF gene polymorphisms in patients with Behçet's uveitis.
Sertoglu E; Yücel Ç; Omma A; Hayran Y; Colak S; Sandıkçı SC; Durukan AH; Ozgurtas T
Adv Clin Exp Med; 2022 Mar; 31(3):231-240. PubMed ID: 34918882
[TBL] [Abstract][Full Text] [Related]
19. Serum vascular endothelial growth factor/soluble vascular endothelial growth factor receptor 1 ratio is an independent prognostic marker in pancreatic cancer.
Chang YT; Chang MC; Wei SC; Tien YW; Hsu C; Liang PC; Tsao PN; Jan IS; Wong JM
Pancreas; 2008 Aug; 37(2):145-50. PubMed ID: 18665074
[TBL] [Abstract][Full Text] [Related]
20. Adenovirus-mediated gene transfer of placental growth factor to perivascular tissue induces angiogenesis via upregulation of the expression of endogenous vascular endothelial growth factor-A.
Roy H; Bhardwaj S; Babu M; Jauhiainen S; Herzig KH; Bellu AR; Haisma HJ; Carmeliet P; Alitalo K; Ylä-Herttuala S
Hum Gene Ther; 2005 Dec; 16(12):1422-8. PubMed ID: 16390273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
